VeriTeQ Corp. to Sponsor & Present at 11th International Committee for Quality Assurance, Medical Technologies & Devices in P...
April 03 2014 - 8:30AM
Business Wire
VeriTeQ Symposium to Educate Leading Plastic
Surgeons on its Q Inside Safety Technology for Breast Implants and
Other Implanted Medical Devices
VeriTeQ Corporation (“VeriTeQ” or “Company”) (OTC Markets:VTEQ),
a provider of implantable medical device identification and
radiation dose measurement technologies, announced today that it is
sponsoring and presenting at the 11th IQUAM (the International
Committee for Quality Assurance, Medical Technologies and Devices
in Plastic Surgery) Congress and Consensus Conference April 10-13,
2014, in Budapest, Hungary. VeriTeQ’s President, Randolph Geissler,
will host a symposium to educate plastic surgeons on the Company’s
Q Inside Safety Technology, currently being used in breast
implants.
VeriTeQ’s FDA cleared Q Inside Safety Technology acts as an
electronic serial number in breast implants and other implantable
and reusable medical devices to give physicians and patients access
to a secure online database to retrieve device-specific data such
as serial number, manufacturer name, date of manufacture, lot
number, volume, size, and other data from the device manufacturer.
Q Inside Safety Technology also provides an extra level of
protection to the patient in the event of a recall or other safety
event.
IQUAM, established in 1992, is a professional data-generating
medical and scientific organization dedicated to the assurance of
the safe use of medical devices, technologies and procedures in
plastic surgery, as well as to ensuring patient safety.
“We look forward to this opportunity to educate the global
plastic surgery community on our Q Inside Safety Technology, which
is now being used in breast implants,” said Scott R. Silverman,
VeriTeQ’s Chairman and CEO. “Following two broad recalls of breast
implants in the EU, we believe patients and surgeons alike will
demand accurate device verification of implants and the added level
of security offered by our Q Inside Safety Technology.”
About IQUAM
IQUAM is a vivid and active Society within the structure of
IPRAS (the International Confederation for Plastic and
Reconstructive & Aesthetic Surgery), with a unique task to
provide guidance and opinions on the role and safety of materials
and techniques employed in this specialty. The most important
product of the biennially organized world conference with delegates
from all Societies of IPRAS (over 100), is the "Position
Statement," which is a public statement circulated among all
interested parties e.g. Scientific Societies, Industry, Government
officials, Individual Plastic Surgeons, Researchers and others.
About VeriTeQ
VeriTeQ develops innovative, proprietary RFID technologies for
implantable medical device identification, and dosimeter
technologies for use in radiation therapy treatment. VeriTeQ offers
the world's first FDA cleared RFID microchip technology that can be
used to identify implantable medical devices, in vivo, on demand,
at the point of care. VeriTeQ's dosimeters provide patient safety
mechanisms while measuring and recording the dose of radiation
delivered to a patient in real time. For more information on
VeriTeQ, please visit www.veriteqcorp.com.
Statements in this press release about our future expectations,
including the likelihood that patients and surgeons alike will
demand accurate device verification of implants and the added level
of security offered by Q Inside Safety Technology, constitute
"forward-looking statements" within the meaning of Section 27A of
the Securities Act of 1933, Section 21E of the Securities Exchange
Act of 1934, and as that term is defined in the Private Litigation
Reform Act of 1995. Such forward-looking statements involve risks
and uncertainties and are subject to change at any time, and our
actual results could differ materially from expected results. These
risks and uncertainties include, without limitation, VeriTeQ’s
ability to raise capital; as well as other risks. Additional
information about these and other factors may be described in
VeriTeQ’s Forms 10-Q, filed on August 9, 2013 and November 14,
2013, and future filings with the Securities and Exchange
Commission The Company undertakes no obligation to update or
release any revisions to these forward-looking statements to
reflect events or circumstances after the date of this statement or
to reflect the occurrence of unanticipated events, except as
required by law.
VeriTeQAllison Tomek,
561-846-7003atomek@veriteqcorp.comorRedChip CompaniesBrendan
Hopkins, 1-800-RED-CHIP (733-2447) Ext 134Bhopkins@redchip.com
VeriTeQ (CE) (USOTC:VTEQ)
Historical Stock Chart
From Mar 2024 to Apr 2024
VeriTeQ (CE) (USOTC:VTEQ)
Historical Stock Chart
From Apr 2023 to Apr 2024